Correlation Between Novo Nordisk and ALK Abell
Can any of the company-specific risk be diversified away by investing in both Novo Nordisk and ALK Abell at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Novo Nordisk and ALK Abell into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Novo Nordisk AS and ALK Abell AS, you can compare the effects of market volatilities on Novo Nordisk and ALK Abell and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Novo Nordisk with a short position of ALK Abell. Check out your portfolio center. Please also check ongoing floating volatility patterns of Novo Nordisk and ALK Abell.
Diversification Opportunities for Novo Nordisk and ALK Abell
0.65 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Novo and ALK is 0.65. Overlapping area represents the amount of risk that can be diversified away by holding Novo Nordisk AS and ALK Abell AS in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ALK Abell AS and Novo Nordisk is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Novo Nordisk AS are associated (or correlated) with ALK Abell. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ALK Abell AS has no effect on the direction of Novo Nordisk i.e., Novo Nordisk and ALK Abell go up and down completely randomly.
Pair Corralation between Novo Nordisk and ALK Abell
Assuming the 90 days horizon Novo Nordisk is expected to generate 1.19 times less return on investment than ALK Abell. But when comparing it to its historical volatility, Novo Nordisk AS is 1.41 times less risky than ALK Abell. It trades about 0.05 of its potential returns per unit of risk. ALK Abell AS is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest 1,400 in ALK Abell AS on September 19, 2024 and sell it today you would earn a total of 805.00 from holding ALK Abell AS or generate 57.5% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 99.79% |
| Values | Daily Returns |
Novo Nordisk AS vs. ALK Abell AS
Performance |
| Timeline |
| Novo Nordisk AS |
| ALK Abell AS |
Novo Nordisk and ALK Abell Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Novo Nordisk and ALK Abell
The main advantage of trading using opposite Novo Nordisk and ALK Abell positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Novo Nordisk position performs unexpectedly, ALK Abell can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ALK Abell will offset losses from the drop in ALK Abell's long position.| Novo Nordisk vs. Nuvalent | Novo Nordisk vs. Arcellx | Novo Nordisk vs. Vaxcyte | Novo Nordisk vs. Viridian Therapeutics |
| ALK Abell vs. Defence Therapeutics | ALK Abell vs. Aileron Therapeutics | ALK Abell vs. Enlivex Therapeutics | ALK Abell vs. Living Cell Technologies |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Complementary Tools
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |